NASDAQ: JBIO
Jade Biosciences Inc Stock Forecast, Predictions & Price Target

Be the first to know when Wall Street analysts revise their JBIO stock forecasts and price targets.

Forecast return on equity

Is JBIO forecast to generate an efficient return?

Company
-27.88%
Industry
115.87%
Market
78.19%
JBIO's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is JBIO forecast to generate an efficient return on assets?

Company
-26.98%
Industry
37.81%
JBIO is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

JBIO earnings per share forecast

What is JBIO's earnings per share in the next 3 years based on estimates from 2 analysts?

Avg 1 year Forecast
-$29.47
Avg 2 year Forecast
-$16.49
Avg 3 year Forecast
-$24.56

JBIO vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
JBIO$12.48N/AN/A
CARM$0.25$1.93+670.00%Buy
APRE$1.85$20.00+981.08%Buy
CANF$1.13$14.00+1,144.44%Strong Buy
ERNA$0.20N/AN/A

Jade Biosciences Stock Forecast FAQ

What is JBIO's earnings growth forecast for 2025-2027?

(NASDAQ: JBIO) Jade Biosciences's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 12.72%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 16.85%.

Jade Biosciences's earnings in 2025 is -$48,960,000.On average, 2 Wall Street analysts forecast JBIO's earnings for 2025 to be -$24,408,438, with the lowest JBIO earnings forecast at -$33,125,720, and the highest JBIO earnings forecast at -$15,691,157. On average, 2 Wall Street analysts forecast JBIO's earnings for 2026 to be -$13,657,072, with the lowest JBIO earnings forecast at -$19,759,161, and the highest JBIO earnings forecast at -$7,554,983.

In 2027, JBIO is forecast to generate -$20,340,351 in earnings, with the lowest earnings forecast at -$20,340,351 and the highest earnings forecast at -$20,340,351.

If you're new to stock investing, here's how to buy Jade Biosciences stock.

What is JBIO's forecast return on equity (ROE) for 2025-2028?

(NASDAQ: JBIO) forecast ROE is -27.88%, which is considered weak.

What is JBIO's Earnings Per Share (EPS) forecast for 2025-2027?

(NASDAQ: JBIO) Jade Biosciences's current Earnings Per Share (EPS) is -$59.50. On average, analysts forecast that JBIO's EPS will be -$29.47 for 2025, with the lowest EPS forecast at -$40.00, and the highest EPS forecast at -$18.95. On average, analysts forecast that JBIO's EPS will be -$16.49 for 2026, with the lowest EPS forecast at -$23.86, and the highest EPS forecast at -$9.12. In 2027, JBIO's EPS is forecast to hit -$24.56 (min: -$24.56, max: -$24.56).

What is JBIO's forecast return on assets (ROA) for 2025-2028?

(NASDAQ: JBIO) forecast ROA is -26.98%, which is lower than the forecast US Biotechnology industry average of 37.81%.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.